Lenz Therapeutics, Inc. <LENZ.O>: Leerink Partners cuts target price to $10 from $20
LENZ•Related News
Sky Harbour CFO Francisco Gonzalez acquires $10,080 of common shares
SKYH•
Franco-Nevada to subscribe A$30 million in Minerals 260 shares in future equity raise
FNV•
Columbia Banking System prices USD 250 million subordinated notes offering
COLB•
Chamberlain University, Covista institution, names Jason Dunne chief academic officer
CVSA•
RF Industries FY26 Q3 net income more than doubles to $1.44 million; net sales rise 21% to $23.96 million
RFIL•